John Varian - Jan 1, 2023 Form 4 Insider Report for ACORDA THERAPEUTICS INC (ACOR)

Role
Director
Signature
/s/ Neil S. Belloff, Attorney-in-Fact
Stock symbol
ACOR
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 06:56 AM
Previous filing
Feb 1, 2022
Next filing
Feb 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACOR Non-Employee Stock Option Award $0 +4.71K $0.00 4.71K Jan 1, 2023 Common Stock 4.71K $0.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option vest in four equal quarterly installments over 12 months with the first quarterly installment vesting on April 1, 2023.